Prevention of serious infections in hereditary hemorrhagic telangiectasia: roles for prophylactic antibiotics, the pulmonary capillaries-but not vaccination
“…Notably, in this group of patients ‘selected’ purely due to the absence of a known family HHT genotype and attendance at the UK reference centre during recruitment to the 100,000 Genomes Project, 36/104 (35%) were categorised with severe hemorrhage, 29/104 (28%) with disproportionate anemia, and 8 (8%) had venous thromboembolic disease. Deep-seated infections affected 13/104 (13%): 10 were in association with concurrent and presumed causative pulmonary AVMs (cerebral and spinal abscesses, spinal discitis, and septic arthritis, due to polymicrobial flora, particularly anaerobic and aerobic commensals of the gastrointestinal and periodontal spaces, as described [19-21]).…”
Section: Resultsmentioning
confidence: 99%
“…Similarly, the observed enrichment of deleterious erythrocyte membrane gene variants in patients experiencing severe deep-seated infection warrants further study in the setting of the common (daily) bacteremias that can seed abscesses by currently unknown mechanisms. [19,48] Mechanistic examination of whether erythrocyte membrane changes modify macrophage opsonisation rates[49] may influence clinical risk assessments, resulting in extension or restriction of HHT patient cohorts for whom prophylactic antibiotics are recommended. [19-22] Notably, in both study cohort and GnomAD 3.1 populations, the greatest proportion of variants were for the red cell membrane category, where relevance to evolutionary fitness could be postulated.…”
Section: Discussionmentioning
confidence: 99%
“…[19,48] Mechanistic examination of whether erythrocyte membrane changes modify macrophage opsonisation rates[49] may influence clinical risk assessments, resulting in extension or restriction of HHT patient cohorts for whom prophylactic antibiotics are recommended. [19-22] Notably, in both study cohort and GnomAD 3.1 populations, the greatest proportion of variants were for the red cell membrane category, where relevance to evolutionary fitness could be postulated.…”
Section: Discussionmentioning
confidence: 99%
“…[16] Counterintuitively, age-adjusted incidence rates of venous thromboembolism (VTE) are several-fold higher in HHT than in the general population,[17,18] while HHT-affected individuals who have VTE are more likely to have a major deep-seated infection that is a particular risk when venous blood can evade pulmonary capillary processing by passage through right-to-left shunts provided by pulmonary AVMs. [19-22] Socio-environmental exposures can aggravate HHT, as detailed elsewhere,[3,16,17,20,23-30] but only a proportion of patients with these added “risk factors” develop the respective clinical phenotypes. There are hints of familial predispositions [16,17,20,23,24,27] supported by case series where occasional individuals had coincidental non-HHT genetic contributors to their complications.…”
Possession of a clinical or molecular disease label alters the context in which life-course events operate, but rarely explains the phenotypic variability observed by clinicians. Whole genome sequencing of unselected endothelial vasculopathy patients demonstrated more than a third had rare, likely deleterious variants in clinically-relevant genes unrelated to their vasculopathy (1 in 10 within platelet genes; 1 in 8 within coagulation genes; and 1 in 4 within erythrocyte hemolytic genes). High erythrocyte membrane variant rates paralleled genomic damage and prevalence indices in the general population. In blinded analyses, patients with greater hemorrhagic severity that had been attributed solely to their vasculopathy had more deleterious variants in platelet (Spearman ρ=0.25, p=0.008) and coagulation (Spearman ρ=0.21, p=0.024) genes. We conclude that rare diseases can provide insights for medicine beyond their primary pathophysiology, and propose a framework based on rare variants to inform interpretative approaches to accelerate clinical impact from whole genome sequencing.
“…Notably, in this group of patients ‘selected’ purely due to the absence of a known family HHT genotype and attendance at the UK reference centre during recruitment to the 100,000 Genomes Project, 36/104 (35%) were categorised with severe hemorrhage, 29/104 (28%) with disproportionate anemia, and 8 (8%) had venous thromboembolic disease. Deep-seated infections affected 13/104 (13%): 10 were in association with concurrent and presumed causative pulmonary AVMs (cerebral and spinal abscesses, spinal discitis, and septic arthritis, due to polymicrobial flora, particularly anaerobic and aerobic commensals of the gastrointestinal and periodontal spaces, as described [19-21]).…”
Section: Resultsmentioning
confidence: 99%
“…Similarly, the observed enrichment of deleterious erythrocyte membrane gene variants in patients experiencing severe deep-seated infection warrants further study in the setting of the common (daily) bacteremias that can seed abscesses by currently unknown mechanisms. [19,48] Mechanistic examination of whether erythrocyte membrane changes modify macrophage opsonisation rates[49] may influence clinical risk assessments, resulting in extension or restriction of HHT patient cohorts for whom prophylactic antibiotics are recommended. [19-22] Notably, in both study cohort and GnomAD 3.1 populations, the greatest proportion of variants were for the red cell membrane category, where relevance to evolutionary fitness could be postulated.…”
Section: Discussionmentioning
confidence: 99%
“…[19,48] Mechanistic examination of whether erythrocyte membrane changes modify macrophage opsonisation rates[49] may influence clinical risk assessments, resulting in extension or restriction of HHT patient cohorts for whom prophylactic antibiotics are recommended. [19-22] Notably, in both study cohort and GnomAD 3.1 populations, the greatest proportion of variants were for the red cell membrane category, where relevance to evolutionary fitness could be postulated.…”
Section: Discussionmentioning
confidence: 99%
“…[16] Counterintuitively, age-adjusted incidence rates of venous thromboembolism (VTE) are several-fold higher in HHT than in the general population,[17,18] while HHT-affected individuals who have VTE are more likely to have a major deep-seated infection that is a particular risk when venous blood can evade pulmonary capillary processing by passage through right-to-left shunts provided by pulmonary AVMs. [19-22] Socio-environmental exposures can aggravate HHT, as detailed elsewhere,[3,16,17,20,23-30] but only a proportion of patients with these added “risk factors” develop the respective clinical phenotypes. There are hints of familial predispositions [16,17,20,23,24,27] supported by case series where occasional individuals had coincidental non-HHT genetic contributors to their complications.…”
Possession of a clinical or molecular disease label alters the context in which life-course events operate, but rarely explains the phenotypic variability observed by clinicians. Whole genome sequencing of unselected endothelial vasculopathy patients demonstrated more than a third had rare, likely deleterious variants in clinically-relevant genes unrelated to their vasculopathy (1 in 10 within platelet genes; 1 in 8 within coagulation genes; and 1 in 4 within erythrocyte hemolytic genes). High erythrocyte membrane variant rates paralleled genomic damage and prevalence indices in the general population. In blinded analyses, patients with greater hemorrhagic severity that had been attributed solely to their vasculopathy had more deleterious variants in platelet (Spearman ρ=0.25, p=0.008) and coagulation (Spearman ρ=0.21, p=0.024) genes. We conclude that rare diseases can provide insights for medicine beyond their primary pathophysiology, and propose a framework based on rare variants to inform interpretative approaches to accelerate clinical impact from whole genome sequencing.
“…The propensity for neurological manifestations increases with larger sized feeding arteries (>3 mm) and with increasing number of PAVMs [ 7 ]. Several proposed mechanisms of BA formation secondary to HHT exist; however, the majority implicate the pulmonary capillaries as either a crucial mechanical filter of septic emboli or being a major contributor to the body’s adaptive immune system attributable to the presence of cytokines, macrophages, and other immunoregulators in close proximity to the capillaries [ 8 , 9 ]. It could also be hypothesized that gastrointestinal and hepatic AVMs would allow a greater baseline translocation of gut bacteria into the portal system through the inferior vena cava, ultimately entering the right heart circulation, and contributing to BA formation in the presence of PAVMs.…”
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant genetic condition associated with mucocutaneous and visceral arteriovenous malformations (AVMs), including pulmonary AVMs, which predispose patients to systemic paradoxical emboli that can lead to brain abscesses. Intraventricular rupture of brain abscess (IVROBA) is a feared complication with a high mortality rate. Here, we present a case with brain abscesses complicated by IVROBA and ventriculitis as the initial presentation of HHT in an undiagnosed patient. We also discuss the diagnostic and therapeutic approach that resulted in this patient’s clinical improvement.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.